308
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Identification of novel DHFR inhibitors for treatment of tuberculosis by combining virtual screening with in vitro activity assay

, &
Pages 1054-1061 | Received 25 Dec 2017, Accepted 28 Feb 2018, Published online: 06 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nizam Uddin, Sinthyia Ahmed, Akib Mahmud Khan, Mohammad Mazharol Hoque & Mohammad A. Halim. (2020) Halogenated derivatives of methotrexate as human dihydrofolate reductase inhibitors in cancer chemotherapy. Journal of Biomolecular Structure and Dynamics 38:3, pages 901-917.
Read now

Articles from other publishers (3)

Amol S Bansode, Mohd Usman Mohd Siddique, Hemant K. Jain & Rajesh B. Patil. (2023) Design, synthesis and molecular dynamic studies of novel imidazo/pyrido-pyrimidine clubbed ethyl-1,2,3,4-tetrahydro-4-phenylpyrimidine-5-carboxylate derivatives as potent anti-tubercular agents. Journal of Molecular Structure, pages 137268.
Crossref
Muthu Kumar T, Rohini K, Nivya James, Shanthi V & Ramanathan K. (2021) Discovery of potent Covid‐19 main protease inhibitors using integrated drug‐repurposing strategy. Biotechnology and Applied Biochemistry 68:4, pages 712-725.
Crossref
Shabnam Shahzad, Muhammad Abdul Qadir, Mahmood Ahmed, Saghir Ahmad, Muhammad Jadoon Khan, Asad Gulzar & Muhammad Muddassar. (2020) Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies. RSC Advances 10:70, pages 42983-42992.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.